Dan discusses the complexities of atherosclerosis, highlighting cases where patients exhibit no major risk factors despite severe heart conditions. He emphasizes the role of APOB-containing lipoproteins as essential building blocks for atherogenesis, suggesting that low levels may slow down the process without entirely halting it. The conversation reveals that while certain patients are uncommon, they challenge existing assumptions about lipid levels and cardiovascular risk.
